Trending News
News
News
Experimental Gene Therapy Reverses Heart Failure in Large Animal Model
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model.
News
How COVID-19 Variants Manipulate Human Cells
Finnish scientists have studied how different COVID-19 variants take over human cells to help the virus spread. By understanding this, we can find better ways to stop the virus with new treatments.
News
Cancer Drug Combo Helps Target Radiation Only to Cancerous Cells
Scientists have developed a way to deliver radiation just to cancerous cells; the therapy combines a drug to mark the cancer cells for destruction and a radioactive antibody to kill them.
News
Potential Drug Targets for Diabetic Kidney Disease Identified
New potential therapeutic targets have been identified for diabetic kidney disease, the leading cause of kidney failure worldwide.
News
Adopting a Healthy Diet Can Reduce Chronic Pain Severity
New research shows that adopting a healthy diet can reduce the severity of chronic pain, presenting an easy and accessible way for sufferers to better manage their condition.
News
Repurposed Drug Shows Promise for Lung Cancer
An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer with KRAS mutations, researchers showed.
News
Fetuses Manage Their Own Immune Responses To Combat Diseases and Infections
Researchers discovered that a fetus has a functional immune system that is well-equipped to combat infections in its developing nervous system, long before birth.
News
Secret Behind Bacterium’s Ability To Withstand Extreme Radiation Revealed
A new study has uncovered how "Conan the Bacterium" can withstand radiation doses thousands of times higher than would kill a human.
News
Weight Loss Drug Shrinks Heart Muscle in Mice and Human Cells
Weight loss drugs like semaglutide may shrink heart muscle as well as waistlines, according to a new study. It found that the popular drug decreased heart muscle mass in lean and obese mice.
News
FDA-Approved Drug Shows Promise in Advanced NSCLC
A UT Southwestern trial found selinexor, an FDA-approved drug, effective in KRAS-mutated non-small cell lung cancer (NSCLC). Combined with chemotherapy, it achieved tumor control in 80% of cases.
Advertisement